Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
39 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
MEI Pharma, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'MEI Pharma, Inc. - Product Pipeline Review - 2014', provides an overview of the MEI Pharma, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of MEI Pharma, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of MEI Pharma, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of MEI Pharma, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the MEI Pharma, Inc.'s pipeline products Reasons to buy - Evaluate MEI Pharma, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of MEI Pharma, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the MEI Pharma, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of MEI Pharma, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of MEI Pharma, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of MEI Pharma, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 MEI Pharma, Inc. Snapshot 5 MEI Pharma, Inc. Overview 5 Key Information 5 Key Facts 5 MEI Pharma, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 MEI Pharma, Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 MEI Pharma, Inc. - Pipeline Products Glance 11 MEI Pharma, Inc. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Phase I Products/Combination Treatment Modalities 12 MEI Pharma, Inc. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 MEI Pharma, Inc. - Drug Profiles 15 pracinostat 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 ME-143 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 ME-344 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 NV-128 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 PWT-143 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 SB-1502 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 MEI Pharma, Inc. - Pipeline Analysis 25 MEI Pharma, Inc. - Pipeline Products by Target 25 MEI Pharma, Inc. - Pipeline Products by Route of Administration 26 MEI Pharma, Inc. - Pipeline Products by Molecule Type 27 MEI Pharma, Inc. - Pipeline Products by Mechanism of Action 28 MEI Pharma, Inc. - Recent Pipeline Updates 29 MEI Pharma, Inc. - Dormant Projects 36 MEI Pharma, Inc. - Locations And Subsidiaries 37 Head Office 37 Appendix 38 Methodology 38 Coverage 38 Secondary Research 38 Primary Research 38 Expert Panel Validation 38 Contact Us 39 Disclaimer 39
List of Tables MEI Pharma, Inc., Key Information 5 MEI Pharma, Inc., Key Facts 5 MEI Pharma, Inc. - Pipeline by Indication, 2014 8 MEI Pharma, Inc. - Pipeline by Stage of Development, 2014 9 MEI Pharma, Inc. - Monotherapy Products in Pipeline, 2014 10 MEI Pharma, Inc. - Phase II, 2014 11 MEI Pharma, Inc. - Phase I, 2014 12 MEI Pharma, Inc. - Preclinical, 2014 13 MEI Pharma, Inc. - Discovery, 2014 14 MEI Pharma, Inc. - Pipeline by Target, 2014 25 MEI Pharma, Inc. - Pipeline by Route of Administration, 2014 26 MEI Pharma, Inc. - Pipeline by Molecule Type, 2014 27 MEI Pharma, Inc. - Pipeline Products by Mechanism of Action, 2014 28 MEI Pharma, Inc. - Recent Pipeline Updates, 2014 29 MEI Pharma, Inc. - Dormant Developmental Projects,2014 36
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.